Opto Biosystems

Its first technology program, SOMA-1 is a tiny neural interface which extracts high fidelity electrical information from the body, using machine learning to derive neural biomarkers associated with patient specific disease state and treatment efficacy.

Opto Biosystems is led and co-founded by former medical device engineer and bioelectronics researcher Ben Woodington and electrical engineer turned neuro-oncology researcher Elise Jenkins who undertook their PhDs in the Bioelectronics Laboratory at the University of Cambridge.

The company is working on a radical new approach for oncology.

Career opportunities at Opto Biosystems